NewsWhat have we been up to?

From partnership and fundraising announcements to co-founders interviews and AI in pharma news, discover in this news section what we have been up to.

Filter by

All News Press Releases Video

2022 2021 2020 2019 2018 2017

Owkin co-founder to argue for a refocusing of AI’s role in medical research at the 40th Annual J.P. Morgan Healthcare Conference

Press Release

CONDOR, an Owkin precision medicine project, is awarded a €10m RHU grant

Owkin and Amgen use AI to improve cardiovascular risk prediction

Partnership

Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects

Partnership

Owkin to improve bile duct cancer treatment through new innovation collaboration

Owkin named MedTech Visionaries, Best Oncology AI Company for Precision Medicine

How Owkin trains AI models without transferring data with Federated Learning

OPTIMA: New research project aims to improve treatment for patients with prostate, breast and lung cancer through AI

Owkin and Cleveland Clinic develop an artificial intelligence model that predicts liver cancer prognosis

AI predicts the risk of recurrence for women with the most common breast cancer

Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms

First AI-Based Tool for Predicting Genomic Subtypes of Pancreatic Cancer (PDAC) shared at ASCO 2021: groundbreaking science from AP-HP Greater Paris University Hospitals and Owkin collaboration

Owkin bolsters the senior team with experienced pharma executives to expand the platform and strategic partnerships

A new consortium of the EU Innovative Medicines Initiative (IMI) will establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine

Owkin Shares New AI-Severity Score for COVID-19 integrating CT Images Published to Nature Communications

Owkin announces a new collaboration to identify High Immunogenic Epitopes and Candidates for COVID-19 and Coronaviruses Future Vaccines.

Owkin and Nantes University Hospital (CHU Nantes) to Advance Cancer Research with Artificial Intelligence

Owkin and Institut Carnot CALYM Launch a Collaboration to Advance Lymphoma Research with AI

Owkin and NYU Langone Health to advance non-small cell lung cancer research with AI

MELLODDY Project Meets its Year One Objective: Deployment of the world’s first secure platform for multi-task federated learning in drug discovery

Owkin published in Nature Communications – A deep learning model to predict RNA-Seq expression of tumors from whole slide images

Owkin and The Bergonié Institute sign further collaboration agreements with cancer research centers in immuno-oncology and sarcoma

Owkin and The University of Pittsburgh launch a collaboration to advance cancer research with AI and FL

The FFCD and Owkin Join Forces to Apply Machine Learning to Digestive Oncology

Artificial Intelligence in Oncology Strategic Alliance Between Owkin and Gustave Roussy Formed to Accelerate Clinical Research

AP-HP and Owkin launch a series of data research projects based on machine learning

Owkin publishes breakthrough research in Nature Medicine: Novel deep-learning approach for predicting and explaining the key prognostic factors in Mesothelioma

NewsWhat have we been up to?

Owkin co-founder to argue for a refocusing of AI’s role in medical research at the 40th Annual J.P. Morgan Healthcare Conference

CONDOR, an Owkin precision medicine project, is awarded a €10m RHU grant

Owkin and Amgen use AI to improve cardiovascular risk prediction

Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects

Owkin to improve bile duct cancer treatment through new innovation collaboration

Owkin named MedTech Visionaries, Best Oncology AI Company for Precision Medicine

How Owkin trains AI models without transferring data with Federated Learning

OPTIMA: New research project aims to improve treatment for patients with prostate, breast and lung cancer through AI

Owkin and Cleveland Clinic develop an artificial intelligence model that predicts liver cancer prognosis

AI predicts the risk of recurrence for women with the most common breast cancer

Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms

First AI-Based Tool for Predicting Genomic Subtypes of Pancreatic Cancer (PDAC) shared at ASCO 2021: groundbreaking science from AP-HP Greater Paris University Hospitals and Owkin collaboration

Owkin bolsters the senior team with experienced pharma executives to expand the platform and strategic partnerships

A new consortium of the EU Innovative Medicines Initiative (IMI) will establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine

Owkin Shares New AI-Severity Score for COVID-19 integrating CT Images Published to Nature Communications

Owkin announces a new collaboration to identify High Immunogenic Epitopes and Candidates for COVID-19 and Coronaviruses Future Vaccines.

Owkin and Nantes University Hospital (CHU Nantes) to Advance Cancer Research with Artificial Intelligence

Owkin and Institut Carnot CALYM Launch a Collaboration to Advance Lymphoma Research with AI

Owkin and NYU Langone Health to advance non-small cell lung cancer research with AI

MELLODDY Project Meets its Year One Objective: Deployment of t​he world’s first secure platform for multi-task federated learning in drug discovery

Owkin published in Nature Communications – A deep learning model to predict RNA-Seq expression of tumors from whole slide images

Owkin and The Bergonié Institute sign further collaboration agreements with cancer research centers in immuno-oncology and sarcoma

Owkin and The University of Pittsburgh launch a collaboration to advance cancer research with AI and FL

The FFCD and Owkin Join Forces to Apply Machine Learning to Digestive Oncology

Artificial Intelligence in Oncology Strategic Alliance Between Owkin and Gustave Roussy Formed to Accelerate Clinical Research

AP-HP and Owkin launch a series of data research projects based on machine learning

Owkin publishes breakthrough research in Nature Medicine: Novel deep-learning approach for predicting and explaining the key prognostic factors in Mesothelioma

MELLODDY Project Meets its Year One Objective: Deployment of the world’s first secure platform for multi-task federated learning in drug discovery